We use cookies for a better user experience. Read our Privacy Policy

I Agree

Genomics Personalized Health Market

Genomics Personalized Health Market (Technology - NGS platforms, RT-PCR, Microarray, and Genetic Analyzers; Test Type - Oncology testing, Infectious Disease Testing, Orphan Disease Testing, Autoimmune Disease Testing, and Obstetrics Testing; End User - Academics & Research Institutes and Diagnostic Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024

Genomics Personalized Health Market - Snapshot

The global genomics personalized health market is primarily driven by the augmented investments in research and development activities related to biomarkers. This system is utilized in the spotting of physiological state of a specific illness in an organism. The high incidence of chronic illnesses, expansion of the pharmaceutical sector, and assessment and prediction of treatment response is likely to bolster the growth of the global genomics personalized health market in the years to come.

In addition to that, the global genomics personalized health market is influenced by the constantly thriving molecular biology sector and innovation in the technology associated with healthcare sector. In comparison with the conventional methods, development and design of the modern day methods of testing come with multiple benefits. This factor is predicted to work in favor of the global genomics personalized health market in near future. Besides, utilizing various technologies, genomics personalized health market offers a wide variety of platforms.

Technological Progress and Innovations are Estimated to Bolster Market Growth

The augmented spending by diagnostic health care and governments is likely to come up as an important factor promoting growth of the global genomics personalized health market. Furthermore, high prevalence of various chronic diseases such as cancer, diabetes is likely to drive the demand for genomics personalized health in the years to come. Based on the type of testing, the market can be broadly categorized into the following

  • Oncology testing
  • Autoimmune disease testing
  • Infectious disease testing
  • Obstetrics testing
  • Orphan disease testing

Besides, expansion in the pool of geriatric population has led to the increased prevalence of various chronic diseases, which is likely to bolster the growth of the global genomics personalized health market in near future.

On the other hand, the market is prophesized to be impeded by the certain factors prevailing in the market. The complex regulatory framework can lead to delays in the approval of novel testing methods, which is likely to restrain growth of the market.

Global Genomics Personalized Health Market: Snapshot

The global market for genomics personalized health is set to create a remarkable incremental opportunity in the come years owing to rise in the biopharmaceutical and healthcare industry. The other drivers for global genomics personalized health the market are increase in prevalence of cancer, increase in geriatric population, increasing attentiveness towards health in emerging economies. Transparency Market Research estimates that the global genomics personalized health market will expand at a CAGR of 14.9% over the forecast period between 2017 and 2025. The global market is estimated to reach US$25,112.5 mn by the end of 2025 from US$7,243.0 mn in 2016. 

Based on technology type the market is segmented as NGS platforms, RT-PCR, microarray, genetic analyzers, and others. In 2016, the NGS platform segment under technology type held a prominent market share of over 32.0% of the global genomics personalized health market. This segment is expected to propel with high growth rate during the forecast period as compared to other segments. Its growth will be associated with introduction of highly efficient technologies and instruments by leading companies such as F. Hoffmann- La Roche, Thermo Fisher Scientific and Illumina Inc. This segment consists of the most prominent best-selling and advance sequencing products used for various genetic analysis. 

genomics personalized health market

Diagnostic Centers and Academic and Research Institutes Lead the Pack due to Growing Investments in R&D

On the basis of end users, the global genomics personalized health market is divided into academics and research institutes, diagnostic centers, and others. Diagnostic centers and academic and research institutes are the major shareholders in the genomics personalized health market with a combined share of around 88.0%, as was recorded in 2016. In April, 2017, the Institute of Medical Genetics and Pathology and Thermo Fisher Scientific at University Hospital Basel signed a strategic agreement for development and validation of next-generation sequencing (NGS)-based cancer diagnostics. Thus, the increasing research activities in the field of genomics along with increase in genetic disorders, increasing strategic alliance between market leaders, and research institutes is expected to drive these segments over the forecast period. 

Asia Pacific to Offer Lucrative Opportunities due to Increasing Awareness about Diseases

The global genomics personalized health market has been segregated into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa in terms of geography. The North America genomics personalized health market accounts for major share of the global market in 2016, followed by Europe.  Asia Pacific is expected to grow at a faster rate due to advanced acceptance rate for innovative technology in the region. Latin America is anticipated to provide lucrative opportunities to the global manufacturers in the region due to increasing awareness and increase in healthcare expenditure, the industry will enhance the demand for genomics personalized health system in this region. Others reason for the market growth are expanding pharmaceutical and biotechnology companies in Mexico and Brazil has provided lucrative growth prospects for the genomics personalized health market in the region. The MEA genomics personalized health market is expected to grow at a lower rate when compared to other regions in global genomics personalized health market. 

Leading players in the genomics personalized health market include are QIAGEN, Illumina, Inc. Thermo Fisher Scientific, Inc. Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Lonza Group, INVITAE Corporation, Genetic Technologies Limited, Interleukin Genetics Inc., Eastern Biotech and Life Sciences, DNA Genotek Inc. (Subsidiary of OraSure Technologies, Inc.), uBiome, Inc., and XCode Life Sciences Private Limited.

The global Genomics Personalized Health market has been segmented as follows:

by Technology

  • NGS platforms
  • RT-PCR
  • Microarray
  • Sequencing and genetic analyzers
  • Others 

by Test Type

  • Oncology testing
  • Infectious disease testing
  • Orphan disease testing
  • Autoimmune disease testing
  • Obstetrics testing
  • Others 

By End-User

  • Academics & Research Institutes
  • Diagnostic Centers
  • Others

by Geography 

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa

Interested in this report?
Get a FREE sample now!

Get Free Sample

*Get Sample Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of genomics personalized health market?

The global genomics personalized health market was worth US$7,243.0 mn and is projected to reach a value of US$25,112.5 mn by the end of 2025

What is the anticipated CAGR of the genomics personalized health market in the forecast period?

Genomics personalized health market is anticipated to grow at a CAGR of 14.9% during the forecast period

Which region is expected to project the highest market share in the global genomics personalized health market?

North America accounted for a major share of the global genomics personalized health market

What are the key driving factors for the growth of the genomics personalized health market?

The major factor driving the demand in global genomics personalized health market is rise in investment regarding research and development of biomarkers

Who are the key players in the global genomics personalized health market?

Key players in the global genomics personalized health market include Thermo Fisher Scientific, Inc., QIAGEN, Illumina, Inc., Bio-Rad Laboratories, Inc., Lonza Group, F. Hoffmann-La Roche AG, INVITAE Corporation, Interleukin Genetics Inc., Genetic Technologies Limited, Eastern Biotech and Life Sciences, uBiome, Inc., DNA Genotek Inc, OraSure Technologies, Inc., and XCode Life Sciences Private Limited. In 2016, among these the 4 top players –Thermofisher Scientific, QIAGEN, Illumina Inc., and F.

Section - 1 Preface 
1.1 Report Scope and Market Segmentation 
1.2 Research Highlights

Section - 2 Assumptions and Research Methodology 
2.1 Assumptions and Acronyms Used
2.2 Research Methodology

Section-3 Executive Summary
3.1 Global Genomics Personalized Health: Market Snapshot
3.2 Global Genomics Personalized Health Market: Opportunity Map

Section-4 Market Overview
4.1 Global Genomics Personalized Health Market: Key Industry Developments

Section-5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
      5.1.2 Drivers
      5.1.3 Restraints
      5.1.4 Opportunity Analysis
5.2 Key Trends
5.3 Porter’s Five Forces Analysis
5.4 Global Genomics Personalized Health Market Revenue Projection
5.5 Genomics Personalized Health Market Outlook

Section-6 Genomics Personalized Health Market Analysis by Technology
6.1 Key Findings
6.2 Introduction
6.3 Global Genomics Personalized Health Market Value Share Analysis, By Technology 
6.4 Global Genomics Personalized Health Market Forecast by Technology 
      6.4.1 NGS Platform
      6.4.2 RT-PCR
      6.4.3 Microarray
      6.4.4 Genetic Analyzers
      6.4.5 Others
6.5 Global Genomics Personalized Health Market Attractiveness Analysis by Technology 
6.6 Key Insights

Section-7 Global Genomics Personalized Health Market Analysis by Test Type
7.1 Key Findings
7.2 Introduction
7.3 Global Genomics Personalized Health Market Value Share Analysis, By Test type
7.4 Global Genomics Personalized Health Market Forecast by Test type
      7.4.1 Oncology Testing
      7.4.2 Infectious Disease Testing
      7.4.3 Orphan Disease Testing
      7.4.4 Autoimmune Disease Testing
      7.4.5 Obstetric Testing
      7.4.6 Others
7.5 Global Genomics Personalized Health Market Attractiveness Analysis by Product
7.6 Key Insights 

Section-8 Global Genomics Personalized Health Market Analysis by End User
8.1 Key Findings
8.2 Introduction
8.3 Global Genomics Personalized Health Market Value Share Analysis, By End User
8.4 Global Genomics Personalized Health Market Forecast by End User
      8.4.1 Academics & Research Institutes 
      8.4.2 Diagnostic Centers
      8.4.3 Others
8.5 Global Genomics Personalized Health Market Attractiveness Analysis by End User
8.6 Key Insights

Section-9 Global Genomics Personalized Health Market Analysis, By Region
9.1 Global Genomics Personalized Health Market Snapshot, by Country
9.2 Introduction
9.3 Global Genomics Personalized Health Market Forecast by Region
9.4 Global Genomics Personalized Health Market Attractiveness Analysis, By Region
9.5 Key Insights

Section-10 North America Genomics Personalized Health Market Analysis
10.1 North America Market Value Share Analysis, By Country
      10.1.1 North America Market Forecast by Country
10.2 North America Market Forecast by Technology
10.3 North America Market Forecast by Test Type
10.4 North America Market Forecast by End User
10.5 North America Market Attractiveness Analysis
10.6 Key Trends

Section-11 Europe Genomics Personalized Health Market Analysis
11.1 Europe Market Value Share Analysis, By Country
      11.1.1 Europe Market Forecast by Country
11.2 Europe Market Forecast by Technology
11.3 Europe Market Forecast by Test Type
11.4 Europe Market Forecast by End User
11.5 Europe Market Attractiveness Analysis
11.6 Key Trends

Section-12 Asia Pacific Genomics Personalized Health Market Analysis
12.1 Asia Pacific Market Value Share Analysis, By Country
      12.1.1 Asia Pacific Market Forecast by Country
12.2 Asia Pacific Market Forecast by Technology
12.3 Asia Pacific Market Forecast by Test Type
12.4 Asia Pacific Market Forecast by End User
12.5 Asia Pacific Market Attractiveness Analysis
12.6  Key Trends

Section-13 Latin America Genomics Personalized Health Market Analysis
13.1 Latin America Market Value Share Analysis, By Country
      13.1.1 Latin America Market Forecast by Country
13.2 Latin America Market Forecast by Technology 
13.3 Latin America Market Forecast by Test Type
13.4 Latin America Market Forecast by End User
13.5 Latin America Market Attractiveness Analysis
13.6 Key Trends

Section-14 Middle East and Africa Genomics Personalized Health Market Analysis
14.1 Middle East and Africa Market Value Share Analysis, By Country
      14.1.1 Middle East and Africa Market Forecast by Country
14.2 Middle East and Africa Market Forecast by Technology
14.3 Middle East and Africa Market Forecast by Test Type
14.4 Middle East and Africa Market Forecast by End User
14.5 Middle East and Africa Market Attractiveness Analysis
14.6 Key Trends

Section-15 Competition Landscape
15.1. Global Genomics Personalized Health Market Share Analysis, by Company 
15.2. Competition Matrix
15.3 Company Profiles
      15.3.1 QIAGEN
               15.3.1.1. Company Details 
               15.3.1.2. Market Presence, By Segment and Geography
               15.3.1.3. Strategic Overview
               15.3.1.4. SWOT analysis
               15.3.1.5. Strategic Overview
      15.3.2 Illumina, Inc. 
               15.3.2.1. Company Details  
               15.3.2.2. Market Presence, By Segment and Geography
               15.3.2.3. Strategic Overview
               15.3.2.4. SWOT analysis
               15.3.2.5. Strategic Overview
      15.3.3 Thermo Fisher Scientific, Inc. 
               15.3.3.1. Company Details  
               15.3.3.2. Market Presence, By Segment and Geography
               15.3.3.3. Strategic Overview
               15.3.3.4. SWOT analysis
               15.3.3.5. Strategic Overview
      15.3.4 Bio-Rad Laboratories, Inc. 
               15.3.4.1. Company Details  
               15.3.4.2. Market Presence, By Segment and Geography
               15.3.4.3. Strategic Overview
               15.3.4.4. SWOT analysis
               15.3.4.5. Strategic Overview
      15.3.5 F. Hoffmann-La Roche AG 
               15.3.5.1. Company Details  
               15.3.5.2. Market Presence, By Segment and Geography
               15.3.5.3. Strategic Overview
               15.3.5.4. SWOT analysis
               15.3.5.5. Strategic Overview
      15.3.6 Lonza Group 
               15.3.6.1. Company Details  
               15.3.6.2. Market Presence, By Segment and Geography
               15.3.6.3. Strategic Overview
               15.3.6.4. SWOT analysis
               15.3.6.5. Strategic Overview
      15.3.7 INVITAE Corporation
               15.3.7.1. Company Details  
               15.3.7.2. Market Presence, By Segment and Geography
               15.3.7.3. Strategic Overview
               15.3.7.4. SWOT analysis
               15.3.7.5. Strategic Overview
      15.3.8 Genetic Technologies Limited 
               15.3.8.1. Company Details  
               15.3.8.2. Market Presence, By Segment and Geography
               15.3.8.3. Strategic Overview
               15.3.8.4. SWOT analysis
               15.3.8.5. Strategic Overview
      15.3.9 Interleukin Genetics Inc.
               15.3.9.1. Company Details  
               15.3.9.2. Market Presence, By Segment and Geography
               15.3.9.3. Strategic Overview
               15.3.9.4. SWOT analysis
               15.3.9.5. Strategic Overview
      15.3.10 Eastern Biotech and Life Sciences 
               15.3.10.1. Company Details  
               15.3.10.2. Market Presence, By Segment and Geography
               15.3.10.3. Strategic Overview
               15.3.10.4. SWOT analysis
               15.3.10.5. Strategic Overview
      15.3.11 DNA Genotek Inc. (Subsidiary of OraSure Technologies, Inc.)
               15.3.11.1. Company Details  
               15.3.11.2. Market Presence, By Segment and Geography
               15.3.11.3. Strategic Overview
               15.3.11.4. SWOT analysis
               15.3.11.5. Strategic Overview
      15.3.12 uBiome, Inc.
               15.3.12.1. Company Details  
               15.3.12.2. Market Presence, By Segment and Geography
               15.3.12.3. Strategic Overview
               15.3.12.4. SWOT analysis
               15.3.12.5. Strategic Overview
      15.3.13 XCode Life Sciences Private Limited 
               15.3.13.1. Company Details 
               15.3.13.2. Market Presence, By Segment and Geography
               15.3.13.3. Strategic Overview
               15.3.13.4. SWOT analysis
               15.3.13.5. Strategic Overview

List of Tables 

Table 01: Global Genomics Personalized Health Market Size (US$ Mn) Forecast, by Technology,     2015–2025
Table 02: Global Genomics Personalized Health Market Size (US$ Mn) Forecast, by Test Type,     2015–2025
Table 03: Global Genomics Personalized Health Market Size (US$ Mn) Forecast, by End-user,     2015–2025
Table 04: Global Genomics Personalized Health Market Size (US$ Mn) Forecast, by Region,     2015–2025
Table 05: North America Genomic Personalized Health Market Size (US$ Mn) Forecast, by     Technology, 2015–2025
Table 06: North America Genomic Personalized Health Market Size (US$ Mn) Forecast, by Test     Type, 2015–2025
Table 07: North America Genomic Personalized Health Market Size (US$ Mn) Forecast, by End-    user, 2015–2025
Table 08: North America Genomic Personalized Health Market Size (US$ Mn) Forecast, by     Country, 2015–2025
Table 09: Europe Genomic Personalized Health Market Size (US$ Mn) Forecast, by Technology,     2015–2025
Table 10: Europe Genomic Personalized Health Market Size (US$ Mn) Forecast, by Test Type,     2015–2025
Table 11: Europe Genomic Personalized Health Market Size (US$ Mn) Forecast, by End-user,     2015–2025
Table 12: Europe Genomic Personalized Health Market Size (US$ Mn) Forecast, by 
Table 13: Asia Pacific Genomics Personalized Health Market Size (US$ Mn) Forecast, by     Technology, 2015–2025
Table 14: Asia Pacific Genomics Personalized Health Market Size (US$ Mn) Forecast, by Test     Type, 2015–2025
Table 15: Asia Pacific Genomics Personalized Health Market Size (US$ Mn) Forecast, by End-    user, 2015–2025
Table 16: Asia Pacific Genomics Personalized Health Market Size (US$ Mn) Forecast, by     Country, 2015–2025
Table 17: Latin America Genomic Personalized Health Market Size (US$ Mn) Forecast, by     Technology, 2015–2025
Table 18: Latin America Genomic Personalized Health Market Size (US$ Mn) Forecast, by Test     Type, 2015–2025
Table 19: Latin America Genomic Personalized Health Market Size (US$ Mn) Forecast, by End-    user, 2015–2025
Table 20: Latin America Genomic Personalized Health Market Size (US$ Mn) Forecast, by     Country, 2015–2025
Table 21: Middle East & Africa Genomic Personalized Health Market Size (US$ Mn) Forecast, by     Technology Type, 2017–2025
Table 22: Middle East & Africa Genomic Personalized Health Market Size (US$ Mn) Forecast, by     Test Type, 2015–2025
Table 23: Middle East & Africa Genomic Personalized Health Market Size (US$ Mn) Forecast, by     End User, 2015–2025
Table 24: Middle East & Africa Genomic Personalized Health Market Size (US$ Mn) Forecast, by     Country, 2015–2025

List of Figures

Figure 1: Global Genomics Personalized Health Market Size (US$ Mn) Forecast, 2015–2025
Figure 2: Market Value Share, by Technology (2017)
Figure 3: Market Value Share, by Test Type (2017)
Figure 5: Market Value Share, by Region (2017)
Figure 4: Market Value Share, by End-user (2017)
Figure 6: Global Genomics Personalized Health Market Value Share Analysis, by Technology, 2016 and 2025
Figure 7: Global Genomics Personalized Health Market Attractiveness Analysis, by Technology, 2017–2025
Figure 9: Global RT-PCR Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 8: Global NGS Platform Market Revenue (US$ Mn) and
Figure 11: Global Genetic Analyzer Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast,     2015–2025
Figure 10: Global Microarray Market Revenue (US$ Mn) and
Figure 12: Global Others Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 13: Global Genomics Personalized Health Market Value Share Analysis, by Test Type, 2017 and 2025
Figure 14: Global Genomics Personalized Health Market Attractiveness Analysis, by Test Type, 2017–2025
Figure 15: Global Genomics Personalized Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Oncology Testing, 2015–2025
Figure 16: Global Genomics Personalized Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Infectious Disease Testing, 2015–2025
Figure 17: Global Genomics Personalized Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), By Orphan Disease Testing, 2015–2025
Figure 18: Global Genomics Personalized Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), By Autoimmune Disease Testing, 2015-2025
Figure 19: Global Genomics Personalized Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), By Obstetric Testing, 2015–2025
Figure 20: Global Genomics Personalized Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), BY Other Testing, 2015-2025
Figure 21: Global Genomics Personalized Health Market Value Share Analysis, by End-user, 2017 and 2025
Figure 22: Global Genomics Personalized Health Market Attractiveness Analysis, by End-user, 2017–2025
Figure 23: Global Academic & Research Institutes Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 24: Global Diagnostic Centers Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 25: Global Genomics Personalized Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
Figure 26: Global Genomics Personalized Health Market Value Share Analysis, by Region, 2017     and 2025
Figure 27: Global Genomics Personalized Health Market Attractiveness Analysis, by Region, 2017–2025
Figure 28: North America Genomic Personalized Health Market Size (US$ Mn) Forecast, 2015–2025
Figure 29: North America Genomic Personalized Health Market Attractiveness Analysis, by Country
Figure 30: North America Genomic Personalized Health Market Value Share Analysis, by Technology, 2017 and 2025
Figure 31: North America Market Value Share Analysis, by Test Type, 2017 and 2025
Figure 32: North America Market Value Share Analysis, by End-user, 2017 and 2025
Figure 33: North America Market Value Share Analysis, by Country, 2017 and 2025
Figure 34: North America Market Attractiveness Analysis, by Technology
Figure 35: North America Market Attractiveness Analysis, by Test Type
Figure 36: North America Market Attractiveness Analysis, by End-user
Figure 37: Europe Genomics Personalized Health Market Size (US$ Mn) Forecast, 2015–2025
Figure 38: Europe Genomics Personalized Health Market Size, Y-o-Y Growth Projections, 2016–2025
Figure 39: Europe Genomics Personalized Health Market Attractiveness Analysis, by Country, 2017–2025
Figure 40: Europe Genomics Personalized Health Market Value Share Analysis, by Technology, 2017 and 2025
Figure 41: Europe Genomics Personalized Health Market Value Share Analysis, by Test Type17 and 2025
Figure 42: Europe Genomics Personalized Health Market Value Share Analysis, by End-user, 2017 and 2025
Figure 43: Europe Genomic Personalized Health Market Value Share Analysis, by Country / Sub-    region, 2017 and 2025
Figure 44: Europe Genomic Personalized Health Market Attractiveness Analysis, by Technology
Figure 45: Europe Genomic Personalized Health Market Attractiveness Analysis, by Test Type
Figure 46: Europe Genomic Personalized Health Market Attractiveness Analysis, by End-user
Figure 47: Asia Pacific Genomics Personalized Health Market Size (US$ Mn) Forecast,
Figure 48: Asia Pacific Genomics Personalized Health Market Y-o-Y Growth (%) Projections, 2016–2025
Figure 49: Asia Pacific Genomics Personalized Health Market Attractiveness Analysis, by     Country, 2017–2025
Figure 50: Asia Pacific Genomics Personalized Health Market Value Share Analysis, by Technology, 2017 and 2025
Figure 51: Asia Pacific Genomics Personalized Health Market Value Share Analysis, by Test Type, 2017 and 2025
Figure 52: Asia Pacific Genomics Personalized Health Market Value Share Analysis, by End-    user, 2017 and 2025
Figure 53: Asia Pacific Genomics Personalized Health Market Value Share Analysis, by Country, 2017 and 2025
Figure 54: Asia Pacific Genomics Personalized Health Market Attractiveness Analysis, by Technology
Figure 55: Asia Pacific Genomics Personalized Health Market Attractiveness Analysis, by Test Type
Figure 56: Asia Pacific Genomics Personalized Health Market Attractiveness Analysis, by End-    user
Figure 57: Latin America Genomics Personalized Health Market Size (US$ Mn) Forecast, 2015–2025
Figure 58: Latin America Genomics Personalized Health Market Y-o-Y Growth (%) Projections, 2016–2025
Figure 59: Latin America Genomic Personalized Health Market Attractiveness Analysis, by     Country
Figure 60: Latin America Genomic Personalized Health Market Value Share Analysis, by Technology, 2017 and 2025
Figure 61: Latin America Genomic Personalized Health Market Value Share Analysis, by Test Type, 2017 and 2025
Figure 62: Latin America Genomic Personalized Health Market Value Share Analysis, by End-    user, 2017 and 2025
Figure 63: Latin America Genomic Personalized Health Market Value Share Analysis, by Country, 2017 and 2025
Figure 64: Latin America Genomic Personalized Health Market Attractiveness Analysis, by Technology
Figure 65: Latin America Genomic Personalized Health Market Attractiveness Analysis, by Test Type
Figure 66: Latin America Genomic Personalized Health Market Attractiveness Analysis, by End- user, 2017-2025
Figure 67: Middle East & Africa Genomics Personalized Health Market Size (US$ Mn) Forecast,2015–2025
Figure 68: Middle East & Africa Genomics Personalized Health Market Y-o-Y Growth (%)     Projections, 2016–2025
Figure 69: Middle East & Africa Genomic Personalized Health Market Attractiveness Analysis, by     Country
Figure 70: Middle East & Africa Genomic Personalized Health Market Value Share Analysis, by Technology, 2017 and 2025
Figure 71: Middle East & Africa Genomic Personalized Health Market Value Share Analysis, by Test Type, 2017 and 2025
Figure 72: Middle East & Africa Genomic Personalized Health Market Value Share Analysis, by End User, 2017 and 2025
Figure 73: Middle East & Africa Genomic Personalized Health Market Value Share Analysis, by Country, 2017 and 2025
Figure 74: Middle East & Africa Genomic Personalized Health Market Attractiveness Analysis, by Technology Type 
Figure 75: Middle East & Africa Genomic Personalized Health Market Attractiveness Analysis, by Test Type
Figure 76: Middle East & Africa Genomic Personalized Health Market Attractiveness Analysis, byEnd User
Figure 77: Global Genomic Personal Health Market Share Analysis, by Company (2016)

Transparency Market Research Plus

Get a free copy if the report you purchased is updated within 90 days

Copyright © Transparency Market Research, Inc. All Rights reserved